JOHNSON & JOHNSON ($JNJ) posted quarterly earnings results for Q1 2026 on Tuesday, April 14th. The company reported earnings of $2.70 per share, beating estimates of $2.70 by $0.00. The company also reported revenue of $24,062,000,000, beating estimates of $23,862,652,556 by $199,347,444.
You can see Quiver Quantitative's $JNJ stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
JOHNSON & JOHNSON Insider Trading Activity
JOHNSON & JOHNSON insiders have traded $JNJ stock on the open market 19 times in the past 6 months. Of those trades, 1 have been purchases and 18 have been sales.
Here’s a breakdown of recent trading of $JNJ stock by insiders over the last 6 months:
- JOAQUIN DUATO (CEO and Chairman of the Board) has made 0 purchases and 2 sales selling 100,000 shares for an estimated $22,122,893.
- JOSEPH J WOLK (Exec VP, CFO) has made 0 purchases and 4 sales selling 89,654 shares for an estimated $21,767,826.
- JOHN C REED (EVP, Innovative Medicine, R&D) has made 0 purchases and 4 sales selling 75,652 shares for an estimated $17,291,026.
- JAMES D. SWANSON (EVP, CIO) has made 0 purchases and 3 sales selling 62,080 shares for an estimated $15,109,758.
- TIMOTHY SCHMID (EVP, WW Chair, MedTech) has made 0 purchases and 3 sales selling 23,945 shares for an estimated $5,852,268.
- VANESSA BROADHURST (EVP, Global Corp Affairs) sold 6,197 shares for an estimated $1,508,287
- ROBERT J DECKER (VP Corporate Controller) sold 4,075 shares for an estimated $1,010,070
- JOHN G MORIKIS purchased 1,250 shares for an estimated $257,687
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
JOHNSON & JOHNSON Hedge Fund Activity
We have seen 1,819 institutional investors add shares of JOHNSON & JOHNSON stock to their portfolio, and 2,056 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AUTO-OWNERS INSURANCE CO removed 69,083,868 shares (-99.5%) from their portfolio in Q1 2026, for an estimated $16,851,282,501
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 46,320,499 shares (-72.8%) from their portfolio in Q4 2025, for an estimated $9,586,027,268
- CAPITAL WORLD INVESTORS added 9,692,884 shares (+inf%) to their portfolio in Q4 2025, for an estimated $2,005,942,343
- FRANKLIN RESOURCES INC removed 5,342,443 shares (-33.1%) from their portfolio in Q4 2025, for an estimated $1,105,618,578
- FMR LLC added 5,333,244 shares (+39.7%) to their portfolio in Q4 2025, for an estimated $1,103,714,845
- VANGUARD GROUP INC added 3,731,074 shares (+1.6%) to their portfolio in Q4 2025, for an estimated $772,145,764
- PRICE T ROWE ASSOCIATES INC /MD/ added 3,655,754 shares (+41.7%) to their portfolio in Q4 2025, for an estimated $756,558,290
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
JOHNSON & JOHNSON Government Contracts
We have seen $28,835,357 of award payments to $JNJ over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- 4569579217!4.5MM LCP PROXIMAL FEMUR: $471,086
- 4568561541!6.5MM/7.3MM CANNULATED SCREW INSTRUMENT: $270,118
- 4568528079!2.7MM/3.5MM VA-LCP ELBOW: $241,322
- 4568544902!SET INSTRMNT IMPLNT 1S: $236,585
- 4569393992!CSS+ LARGE SET: $218,394
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
JOHNSON & JOHNSON Congressional Stock Trading
Members of Congress have traded $JNJ stock 12 times in the past 6 months. Of those trades, 4 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $JNJ stock by members of Congress over the last 6 months:
- REPRESENTATIVE RICHARD MCCORMICK has traded it 3 times. They made 1 purchase worth up to $15,000 on 11/05 and 2 sales worth up to $30,000 on 03/19.
- REPRESENTATIVE LLOYD DOGGETT has traded it 2 times. They made 2 purchases worth up to $30,000 on 03/10, 12/09 and 0 sales.
- REPRESENTATIVE THOMAS H. KEAN, JR. has traded it 2 times. They made 0 purchases and 2 sales worth up to $100,000 on 01/23, 11/20.
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
JOHNSON & JOHNSON Analyst Ratings
Wall Street analysts have issued reports on $JNJ in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Morgan Stanley issued a "Overweight" rating on 01/28/2026
- TD Cowen issued a "Buy" rating on 01/22/2026
- Goldman Sachs issued a "Buy" rating on 12/19/2025
- Guggenheim issued a "Buy" rating on 12/05/2025
To track analyst ratings and price targets for JOHNSON & JOHNSON, check out Quiver Quantitative's $JNJ forecast page.
JOHNSON & JOHNSON Price Targets
Multiple analysts have issued price targets for $JNJ recently. We have seen 16 analysts offer price targets for $JNJ in the last 6 months, with a median target of $245.0.
Here are some recent targets:
- Terence Flynn from Morgan Stanley set a target price of $267.0 on 04/10/2026
- Michael Nedelcovych from TD Cowen set a target price of $250.0 on 04/08/2026
- Shagun Singh from RBC Capital set a target price of $255.0 on 03/30/2026
- Matt Miksic from Barclays set a target price of $234.0 on 03/19/2026
- Morten Herholdt from HSBC set a target price of $280.0 on 03/17/2026
- Joanne Wuensch from Citigroup set a target price of $274.0 on 03/11/2026
- Chris Schott from JP Morgan set a target price of $250.0 on 03/05/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
